. European Microbiology Conference 2018 .

Speakers

Walid El Azab  

Walid El Azab
Steris Corporation, Belgium

Walid  is a Technical Services Manager for the Life Sciences Division of STERIS Corporation.  He currently provides technical support related to cleaning chemistries, disinfectants and sterility assurance products and their application and validation. His areas of expertise include both upstream and downstream biopharmaceutical operation and validation. Walid has held various positions including Project Manager, Inspection Readiness Manager, Quality and Regulatory Manager, and Qualified Person (QP). Walid earned a Master’s degree in Industrial Pharmaceutical Sciences from the University of Liege, Belgium and is green belt certified.

 
Dr Isabelle Bekeredjian-Ding  

Dr Isabelle Bekeredjian-Ding
Paul-Ehrlich Institut, German Federal Agency for Vaccines and Biomedicines

Isabelle Bekeredjian-Ding is head of the Division of Microbiology at Paul-Ehrlich-Institut (PEI)  and associate professor at the University of Bonn. Before she joined PEI she was deputy director of the Institute for Medical Microbiology, Immunology and Parasitology at the University Hospital in Bonn. After medical school and a PhD equivalent in Heidelberg, Germany, she received clinical training in Munich and the medical microbiology training in Heidelberg. Her research background includes two postdoctoral fellowships in Dallas, TX and in Munich, Germany. Dr. Bekeredjian-Ding is member of the advisory board of the ECA Foundation Pharmaceutical Microbiology Working Group.

 
Dr Elena Bolchakova  

Dr Elena Bolchakova
Sr.Staff Scientist, Themo Fisher Scientific

Dr Elena Bolchakova graduated from the Biology department of Moscow State University in Russia and received her PhD degree from the Institute of Molecular Genetics in Moscow. After moving to the United States, she joined Applied Biosystems as a postdoctoral fellow and then became a research scientist. During her tenure with Applied Biosystems/Life Technologies/Thermo Fisher Scientific Dr Bolchakova led development of several new commercial products in the area of Sanger sequencing, qPCR detection of microbial pathogens and biological contaminants in pharmaceutical products, MicroSEQ®  ID microbial identification system and 16S Metagenomic analysis of microbial communities using massively parallel sequencing. Dr Bolchakova is currently working on a new rapid detection method of viral contamination in cell cultures based on NGS of PCR-amplified viral genomic signatures.

 
Dr Marja Claassen-Willemse  

Dr Marja Claassen-Willemse
MSD Oss, The Netherlands

Maria Claassen studied Biology at the Radboud university of Nijmegen and got her PhD on Virology at the Utrecht University. After a post doc position in the field of Immunology at the Erasmus MC in Rotterdam, she joined MSD where she had varying positions in development, QC and manufacturing. Currently she is Senior Specialist of the Global Center of Expertise Microbiology, The Netherlands, involved in rapid microbiological method deployment in the QC laboratories of MSD.

 
 Sinéad Cowman  

Sinéad Cowman
EU Business Development Manager - Informatics, Lonza, UK

Sinéad studied Microbiology at Trinity College Dublin and has over 15 years’ experience in QC Microbiology. She joined Lonza in 2005 to manage their endotoxin business in Ireland  and for the past 7 years has been involved in their informatics division. She has worked with many organizations from small biotech to global pharmaceutical companies to implement and validate a paperless solution for QC Microbiology and help them achieve an automated integrated approach to data collection and evaluation. Currently studying Strategy and Innovation at Oxford University she is focused on driving the strategic direction of informatics at Lonza.

 
Dr Sven M. Deutschmann  

Dr Sven M. Deutschmann
Roche Diagnostics GmbH, Penzberg, Germany

In 1995 Sven Deutschmann joined Roche Diagnostics GmbH. Dr Sven M. Deutschmann studied at the University of Brunswick. He holds a PhD (1994) and a MSc/Diplom (1991) in Biology. In 1995 he joined Roche Diagnostics GmbH. In the past two decades he took over increasing responsibilities within the local and global Roche QC Network. He has been extensively involved in various fields of Quality Control - Microbiology, Bioassay, Adventitious Agents Testing, Environmental Monitoring, Cleaning Analytics/Validation, and many more. Currently, Sven is Head of a Corporate Function within the Global QC Network of Roche called “Analytical Science and Technology – Adventitious Agents Testing & Alternative Microbiological Methods”.

 
Carolin Fromm  

Carolin Fromm
Labor L+S AG, Bad Bocklet, Germany

Carolin Fromm studied Bioanalytics (Master) at the University of Applied Science Coburg. Since 2015 she is head of department research and development at Labor L+S AG. Her responsibility includes the project “Implementation and validation of a rapid sterility test” as well as the implementation of new customized microbiological methods.

 
Rob van Gemmeren  

Rob van Gemmeren
Project Manager Data Integrity, Vivenics

Rob studied Chemistry (Master) at the Radboud University Nijmegen in the Netherlands. He has extensive ICT project management experience. After working for Akzo Nobel since 1989, he joined Organon (nowadays MSD) in 2002 where he was involved in the development of data management and visualization software (‘decision support tools’) for pharmaceutical research. Rob joined Vivenics, an Informatics Consultancy firm, early 2016 to manage data integrity compliance projects within the pharmaceutical industry.

 
Dr Marcel Goverde  

Dr Marcel Goverde
MGP Consulting, Switzerland

Marcel Goverde earned his PhD in ecology at the University of Basel where he subsequently was employed as an aca-demic tutor. 2002 to 2010 he was leading the quality control lab for non-sterile products as well as the lab for research & development of microbiological methods at F. Hoffmann-La Roche Ltd in Basel. After one year at Novartis ChemOps Ltd. running the microbial QC lab for API and drug development, he started his own company for consulting and training. Furthermore he is the Swiss delegate for group 1 (microbiological and statistical methods) and vice-chair of the ECA Pharmaceutical Microbiology Working Group.

 
Jeanne Grosselin  

Dr Jeanne Grosselin
bioMérieux, France

Dr Jeanne Grosselin graduated as engineer from a French scientific school (INSA, Lyon) and received her PhD degree from University of Paris Sud 11 in France. In 2013 she started her carrier at bioMérieux as R&D senior scientist. She worked for 3 years on a rapid alternative microbiological method based on a solid cytometry technology. She is currently responsible of innovative projects for pharmaceutical industry culture media.

 
Pieta IJzerman-Boon  

Pieta IJzerman-Boon
Associate Director Quantitative Sciences/Center for Mathematical Sciences-Europe, MSD, The Netherlands

Pieta C. IJzerman-Boon received her education at the University of Twente, the Netherlands. In 1995 she obtained her M.Sc. degree in Applied Mathematics, followed by a Ph.D. in Statistics in 1999. She joined MSD after her PhD.  In 2011 she moved to the non-clinical statistics group in the company, where she currently works as a senior statistician at the Center for Mathematical Sciences.

 
Prof. Edwin van den Heuvel  

Prof. Edwin van den Heuvel
University of Technology, Eindhoven, The Netherlands

Edwin obtained his Ph.D. in 1996. He started as a consultant in industrial statistics and afterwards he became head of the statistics department at MSD. Since 2010 he is fulltime professor Medical Statistics at the UMCG and since October 2014 he is Professor at the TU/e department of Mathematics and Computer Science will be closely involved with the development of the Data Science Center Eindhoven (DSC/e).

 
Dr Gerald Kindermann  

Dr Gerald Kindermann
F. Hoffmann – La Roche, Basel, Switzerland

Dr Gerald Kindermann is “QA and GMP Compliance Lead for global QC”  working in the Global Quality Group at Roche. Before that he held several positions within Roche, amongst others Group Leader Quality Control and Quality Manager for the Supply Center.

 
Scott Kaszuba  

Scott Kaszuba
QC Manager, Pfizer

Scott Kaszuba studied Biology at the University of Massachusetts at Lowell.  He has been working at the Andover MA facility for fifteen years working first for Wyeth Pharmaceuticals, which was later acquired by Pfizer.  In his current position, Scott is the manager overseeing all non-testing activities performed within the QC Microbiology group.

 
Di Morris  

Di Morris
Audit Manager CAG, GSK, United Kingdom

Di Morris worked more than 6 years as Midicines Inspector for the UK Department of Health. After 4 years of consultancy in Quality Assurance and as QP, she joined GSK in 2015. She has a broad experience in regulatory requirements, microbiology and quality topics.

 
Dr Antja Motzek  

Dr Antje Motzek
Quality Assurance, Labor L+S AG, Bad Bocklett, Germany

Antje Motzek studied molecular and cell biology in Mainz and Erlangen-Nürnberg. She worked then as scientist at the Institute for Human Genetics in Mainz. After further trainings in QM and project management she is employed in the Quality Assurance of Labor L+S AG since 2016.

 
Dr Youwen Pan  

Dr Youwen Pan
QC Scientist/Microbiologist at Genentech

Youwen studied at the Lanzhou University and the North Carolina State University Biology and Microbiology. After his Ph.D. he worked as research scientist at Baxter. Since 2013 he is employed at Genentech, where he is involved in Rapid Microbiological Methods Development; Global Change Control and Global CAPA.

 
 Dr Petra Parizek  

Dr Petra Parizek
Laves Arzneimittel, Switzerland

Petra Parizek studied Biology at the University of Zurich and got her PhD in Biochemistry. Since 2013, she is working at Laves Arzneimittel GmbH, Schoetz, Switzerland, a company with focus on biotechnological production of pharmaceuticals and food supplements. As Head of QC, Petra Parizek is responsible for the Quality Control of starting materials, In-Process-Control samples and products including microbiological, chemical and molecular biological analytics of QC as well as Environmental Monitoring.

 
 Mousumi Paul  

Mousumi Paul
Director Manufacturing and Quality, Center of Expertise Microbiology, Merck, Sharp and Dohme

Mousumi is the Global deployment lead for Rapid Micro Methods at MSD. She is also responsible for managing the Quality and Compliance initiatives within Center Of Expertise Microbiology. Prior to this role Mousumi worked in Biologics Quality Operations where she was the Quality lead for new product launches. Mousumi has over eighteen years of diverse experience from development through technology transfer, manufacturing and quality support for vaccines and biologics. Mousumi has directed transformation efforts and operational excellence projects focused on enhancements to sterility assurance. She holds a Master’s Degree in Microbiology and in Pharmacology and a Master of Business Administration degree in Management.